Cargando…
Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations
Current treatments that use hematopoietic progenitor cell (HPC) transplantation in acute myeloid leukemia (AML) patients substantially reduce the risk of relapse, but are limited by the availability of immune compatible healthy HPCs. Although cellular reprogramming has the potential to provide a nov...
Autores principales: | Salci, Kyle R, Lee, Jong-Hee, Laronde, Sarah, Dingwall, Steve, Kushwah, Rahul, Fiebig-Comyn, Aline, Leber, Brian, Foley, Ronan, Dal Cin, Arianna, Bhatia, Mickie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691325/ https://www.ncbi.nlm.nih.gov/pubmed/25764124 http://dx.doi.org/10.1002/stem.1994 |
Ejemplares similares
-
Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs
por: Boyd, Allison L., et al.
Publicado: (2014) -
Abnormal dopamine receptor signaling allows selective therapeutic targeting of neoplastic progenitors in AML patients
por: Aslostovar, Lili, et al.
Publicado: (2021) -
In Utero Transplantation of Expanded Autologous Amniotic Fluid Stem Cells Results in Long‐Term Hematopoietic Engraftment
por: Loukogeorgakis, Stavros P., et al.
Publicado: (2019) -
An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE‐IHD clinical trial
por: Choudhury, Tawfiq, et al.
Publicado: (2016) -
Reprogramming of Acute Myeloid Leukemia Patients Cells: Harboring Cancer Mutations Requires Targeting of AML Hierarchy
por: Golubeva, Diana, et al.
Publicado: (2023)